Methylmercury-Dependent Increases in Fluo4 Fluorescence in Neonatal Rat Cerebellar Slices Depend on Granule Cell Migrational Stage and GABAA Receptor Modulation.
Calcium Contributes to the Cytotoxic Interaction Between Diclofenac and Cytokines.
Five Michigan State University College of Osteopathic Medicine faculty members received the College Advisory Council Awards at the faculty meeting on Sept. 29. Margaret Kingry, associate professor of pediatrics, presented the recognition on behalf of the council.
Congratulations Nikita on winning a best presentation award at the colloquium in Toledo.
Congratulations to the SUMMER 2014 graduates of our MS in Pharmacology & Toxicology program
The National Institute of Health / National Heart, Lung and Blood Institute has awarded a grant to Michigan State University ( P.I. Dr. Stephanie Watts, Department of Pharmacology & Toxicology ) for the project “Chemerin as a Link Between Obesity and Blood Pressure”
"Most of the time, Sheri Hicks doesn’t wear makeup or style her hair. It isn’t because she doesn’t care about how she looks or doesn’t want to be bothered. It’s because she physically can’t do it. Hicks, 42, of Farmington has an autoimmune disorder called scleroderma, which causes fibrosis, or the thickening and hardening of the skin, along with pain, sensitivity to heat and cold and other effects."
U-M and MSU researchers have joined together to develop novel compounds for the treatment of scleroderma, supported by a three-year, $2M award from the National Institutes of Health (NIH). "Dr. [Scott] Larsen is a member of a team of basic science and clinician researchers at U-M and MSU who have joined forces to further the development of novel compounds for the treatment of scleroderma. The initial discovery was made by Dr. Richard Neubig, chair of the pharmacology and toxicology department at Michigan State University, via high-throughput screening at the Center for Chemical Genomics at the U-M Life Sciences Institute."
Congratulations to the Spring 2014 graduates of our MS in Pharmacology & Toxicology program.
"[EAST] LANSING, Mich. - Groundbreaking research is being done at Michigan State University for a debilitating disease that hardens skin. "
Each year the Society of Toxicology presents awards to distinguished toxicologists and students from around the world. At their 2014 annual meeting, a diverse group of faculty and students from Michigan State University were selected
From MSU Today 4/3/2014 - "Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers, including a Michigan State University professor, is looking to change that."